MoonLake Immunotherapeutics (MLTX) Stock Price
$9.41 2%
to add to portfolio
AI Score
-
Alternative
10 -
Fundamental
2 -
Technical
3
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on MoonLake Immunotherapeutics, AI stock picks, stock alerts and much more.
MLTX AI Stock Analysis
AI stock analysis for MLTX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like MoonLake Immunotherapeutics (MLTX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
MoonLake Immunotherapeutics (MLTX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of MoonLake Immunotherapeutics (MLTX), currently trading at $9.41, will... Sign up to access price prediction.
About MLTX
-
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies.
-
Symbol
MLTX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
597.2M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$20.82 0.7% |
7 |
 |
Inovio Pharmaceuticals INO |
$2.3 3.4% |
2 |
 |
Moderna MRNA |
$26.34 1.9% |
4 |
 |
Anavex Life Sciences AVXL |
$8.77 6.2% |
5 |
 |
BridgeBio Pharma BBIO |
$53.28 0.1% |
5 |
News
MLTX Alternative Data
Web Traffic
MoonLake Immunotherapeutics receives an estimated 22709 monthly visitors to moonlaketx.com.
-
Web Traffic
22709
-
Change from Previous Month
48.6%
-
3 Month Change
36.3%
-
YoY Change
36.3%
Stocktwits Mentions
MoonLake Immunotherapeutics has been mentioned an estimated 678 times on Stocktwits over the last 24 hours.
-
Stocktwits Mentions
678
-
Daily Change
20.6%
-
1 Month Change
4742.9%
Twitter Followers
MoonLake Immunotherapeutics has 297 Twitter Followers on its main Twitter (also known as X) account, which is up by 91.6% over the last month.
-
Twitter Followers
297
-
Daily Change
1.4%
-
1 Month Change
91.6%
-
3 Month Change
135.7%
-
YoY Change
135.7%
LinkedIn Followers
8,126 are following MoonLake Immunotherapeutics on LinkedIn, up by 3.6% over the last month.
-
LinkedIn Followers
8126
-
Daily Change
0%
-
1 Month Change
3.6%
-
3 Month Change
12%
-
YoY Change
12%
Job Postings
MoonLake Immunotherapeutics has an estimated 0 open job postings, which is down -100% over the last month.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
-
YoY Change
100%
LinkedIn Employees
According to LinkedIn, MoonLake Immunotherapeutics has 142 employees, up by 2.9% over the last month.
-
LinkedIn Employees
142
-
Daily Change
0%
-
1 Month Change
2.9%
-
3 Month Change
12.7%
-
YoY Change
12.7%
Reddit Mentions
MoonLake Immunotherapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Sentiment
The sentiment Score for MoonLake Immunotherapeutics is 42 out of 100, which represents a bearish sentiment.
-
Reddit Sentiment
41.625
News Mentions
MoonLake Immunotherapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
MLTX Financials
MLTX Key Metrics
-
Total Revenue
$101.9K
-
Net Income
-$45.6M
-
Earnings per Share
$1.16
-
Free cash flow
-$117B
-
EBITDA
-$48.3M
-
EBITDA Ratio
-474.021
-
Total Assets
$477.9B
MLTX 2-year Revenue & Income
MLTX 2-year Free Cash Flow
MLTX Technicals
MLTX SMA
MLTX RSI
FAQ
What's the current price of MoonLake Immunotherapeutics (MLTX) Stock?
The price of an MoonLake Immunotherapeutics (MLTX) share is $9.41.
What's the market cap of MoonLake Immunotherapeutics?
The current market cap of MoonLake Immunotherapeutics is 597.2M.
What are some stocks similar to MoonLake Immunotherapeutics (MLTX) that investors often compare it to?
MoonLake Immunotherapeutics (MLTX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for MoonLake Immunotherapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast MoonLake Immunotherapeutics' stock price to be around $9.86 in 2026. Starting from the current price of $9.41, this represents a 4.8% change in price, indicating a neutral outlook for the stock.
How to buy MoonLake Immunotherapeutics (MLTX) Stock?
MoonLake Immunotherapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy MoonLake Immunotherapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.